Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 2;5(1):47.
doi: 10.1186/s40249-016-0143-8.

Epidemiological characteristics of human prion diseases

Affiliations
Review

Epidemiological characteristics of human prion diseases

Cao Chen et al. Infect Dis Poverty. .

Abstract

Human prion diseases are a group of transmissible, progressive, and invariably fatal neurodegenerative disorders, which include Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia. Human prion diseases affect approximately 1-2 persons per million worldwide annually, occurring in sporadic, inherited, and acquired forms. These diseases have attracted both scientific and public attention not only because of their mysterious pathogen, but also due to their considerable threat to public health since the emergence of the variant CJD.There are still no specific therapeutic and prophylactic interventions available for prion diseases, thus active surveillance of human prion diseases is critical for disease control and prevention. Since 1993, CJD surveillance systems have been established in many countries and regions, and several long-term multinational cooperative projects have been conducted.In this paper, the epidemiological characteristics of various human prion diseases and the active surveillance systems pertaining to them in different countries and regions are summarized and reviewed.

Keywords: Creutzfeldt-Jakob disease; Epidemiology; Prion disease; Surveillance.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The mean mortality rates per million from sCJD according to the data of the CJD International Surveillance Network from 1993 to 2013. a Data from the member states of the CJD International Surveillance Network. The mortality rate of one per million is marked with a dotted line. b The mean mortality rates per million of all member states. Solid line represents the fitting trend
Fig. 2
Fig. 2
The distribution ofdura mater graft-associated and hGH-related iCJD casesglobally
Fig. 3
Fig. 3
Number of deaths from vCJD in the UK and outside of the UK from 1995 to 2015
Fig. 4
Fig. 4
Countries (marked in gray) where active CJD surveillance is officially conducted under the framework of the CJD International Surveillance Network

Similar articles

  • An overview of human prion diseases.
    Imran M, Mahmood S. Imran M, et al. Virol J. 2011 Dec 24;8:559. doi: 10.1186/1743-422X-8-559. Virol J. 2011. PMID: 22196171 Free PMC article. Review.
  • The many faces of human prion diseases in Belgium and the world.
    Van Everbroeck B, Pals P, Quoilin S, Martin JJ, Cras P. Van Everbroeck B, et al. Acta Neurol Belg. 2001 Jun;101(2):81-7. Acta Neurol Belg. 2001. PMID: 11486562 Review.
  • Prion diseases.
    McKintosh E, Tabrizi SJ, Collinge J. McKintosh E, et al. J Neurovirol. 2003 Apr;9(2):183-93. doi: 10.1080/13550280390194082. J Neurovirol. 2003. PMID: 12707849 Review.
  • Prion diseases.
    Ironside JW, Ritchie DL, Head MW. Ironside JW, et al. Handb Clin Neurol. 2017;145:393-403. doi: 10.1016/B978-0-12-802395-2.00028-6. Handb Clin Neurol. 2017. PMID: 28987186 Review.
  • Updated global epidemiology atlas of human prion diseases.
    Gao LP, Tian TT, Xiao K, Chen C, Zhou W, Liang DL, Cao RD, Shi Q, Dong XP. Gao LP, et al. Front Public Health. 2024 Jun 13;12:1411489. doi: 10.3389/fpubh.2024.1411489. eCollection 2024. Front Public Health. 2024. PMID: 38939567 Free PMC article.

Cited by

References

    1. Prusiner SB. The prion diseases. Brain Pathol. 1998;8(3):499–513. doi: 10.1111/j.1750-3639.1998.tb00171.x. - DOI - PMC - PubMed
    1. Knight R, Brazier M, Collins SJ. Human prion diseases: cause, clinical and diagnostic aspects. Contrib Microbiol. 2004;11:72–97. doi: 10.1159/000077051. - DOI - PubMed
    1. Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95(23):13363–83. doi: 10.1073/pnas.95.23.13363. - DOI - PMC - PubMed
    1. Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, et al. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science. 2003;300(5619):640–3. doi: 10.1126/science.1083320. - DOI - PubMed
    1. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci. 2001;24:519–50. doi: 10.1146/annurev.neuro.24.1.519. - DOI - PubMed

LinkOut - more resources